From genome-wide association studies to rational drug target prioritisation in inflammatory arthritis
Early identification of genetically validated drug targets can increase the chances of successful late-stage drug development. 81 high-quality genome-wide association studies (GWAS) in diseases related to inflammatory arthritis have been curated into the GWAS catalogue; however, translation of genet...
Main Authors: | , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|